PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Feb-2021 4D pharma presents update on oncology program 4D pharma
03-Feb-2021 ONTOZRY™ (cenobamato) riceve il parere positivo del CHMP per l’uso come terapia aggiuntiva nelle crisi epilettiche a esordio focale non controllate negli adulti* Arvelle Therapeutics
03-Feb-2021 Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements Takeda
03-Feb-2021 Noble Launches Human Factors Engineering Services to Support Product Development and US FDA Approval of Medical Devices and Combination Products Noble
03-Feb-2021 Bayer launches The Nutrient Gap Initiative to Expand Access to Vitamins and Minerals for 50 Million People Annually Worldwide by 2030 Bayer
03-Feb-2021 Nass Valley Gateway Ltd.: Nass Valley Gateway Announces It Will Launch Its Newly Renovated Website on February 15th, 2021 Nass Valley Gateway Ltd.
03-Feb-2021 Three Key Start-ups Join SMi’s 2nd Annual AI in Drug Discovery Virtual Conference  SMi Group
03-Feb-2021 Tiziana Life Sciences CEO Discusses COVID-19 Trial Data in Exclusive Interview Tiziana Life Sciences
03-Feb-2021 BD Announces Assay for Identification of COVID-19 Patients at Increased Relative Risks of Intubation with Mechanical Ventilation, Mortality at Hospital Admission Now Available in Europe B3C newswire
03-Feb-2021 XPhyto Therapeutics Corp.: XPhyto Announces Psychedelic Pharmaceutical Production Agreement XPhyto Therapeutics Corp.
03-Feb-2021 G&L Scientific inicia su expansión en España Sciad Newswire
02-Feb-2021 CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing Multiple Sclerosis Genmab A/S
02-Feb-2021 AMARIN RECEIVES POSITIVE CHMP OPINION FOR ICOSAPENT ETHYL FOR CARDIOVASCULAR RISK REDUCTION Amarin Corporation plc
02-Feb-2021 Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences Sosei Heptares
02-Feb-2021 Janssen Announces CAR-T Therapy Ciltacabtagene Autoleucel (Cilta-cel) Accepted for Accelerated Assessment in Europe for the Treatment of Patients with Heavily Pretreated Multiple Myeloma Janssen
02-Feb-2021 RauCon Guarantees Business Development Event Planning Dependability RauCon
02-Feb-2021 Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications Recipharm and Medspray
02-Feb-2021 ONTOZRYTM (cenobamate) receives positive CHMP opinion for the adjunctive treatment of uncontrolled focal onset seizures in adults* Arvelle Therapeutics
02-Feb-2021 Novartis receives positive CHMP opinion for Kesimpta® (ofatumumab), a self-administered treatment for adult patients with relapsing multiple sclerosis with active disease Novartis
02-Feb-2021 Bayer receives approval in the UK for Xarelto® (rivaroxaban) to treat children with venous thromboembolism (VTE) and to prevent VTE recurrence Bayer